The FDA's usual end-of-year flurry of regulatory approvals is a little lighter than usual, but the agency has delivered some end-of-year cheer to Vanda Pharma after giving the go-ahead to its drug for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results